Symbols / TNYA Stock $0.69 -6.53% Tenaya Therapeutics, Inc.
TNYA (Stock) Chart
About
No company description available for this symbol.
Stock Fundamentals
Scroll to Statements| Market Cap | 159.73M | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | $0.74 | Price | $0.69 | Change | -6.53% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- William Blair Analysts Confident on Tenaya Therapeutics (TNYA) Product Pipeline - Yahoo Finance ue, 24 Mar 2026 07
- TNYA Tenaya Therapeutics Inc. shares gain over 4 percent after Q4 2025 earnings narrowly top analyst consensus estimates. - Crowd Consensus Signals - UBND thành phố Hải Phòng hu, 23 Apr 2026 01
- TNYA News & Events - Intellectia AI Wed, 22 Apr 2026 18
- $TNYA stock is up 8% today. Here's what we see in our data. - Quiver Quantitative hu, 05 Mar 2026 08
- TNYA (Tenaya Therapeutics) posts slight Q4 2025 EPS beat, but shares drop 5.2 percent on soft investor sentiment. - Trending Social Stocks - UBND thành phố Hải Phòng hu, 23 Apr 2026 00
- When Will Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Become Profitable? - Yahoo Finance Wed, 22 Apr 2026 11
- TNYA.O Forecast — Price Prediction for 2026. Should I Buy TNYA.O? - Intellectia AI Wed, 22 Apr 2026 18
- $TNYA stock is up 20% today. Here's what we see in our data. - Quiver Quantitative hu, 29 Jan 2026 08
- TNYA Should I Buy - Intellectia AI Wed, 22 Apr 2026 18
- Tenaya Therapeutics, Inc. (TNYA) Reports Q4 EPS of (12c), In Line with Consensus - Yahoo Finance Fri, 20 Mar 2026 07
- Will Tenaya Therapeutics (NASDAQ:TNYA) Spend Its Cash Wisely? - Yahoo Finance hu, 20 Nov 2025 08
- TNYA.O Technical Analysis & Stock Price Forecast - Intellectia AI Wed, 22 Apr 2026 18
- AI Investing Insights - Official Homepage - Intellectia AI™ - Intellectia AI Wed, 22 Apr 2026 19
- TNYA.O Earning Date, Earning Analysis and Earning Prediction - Intellectia AI Wed, 22 Apr 2026 18
- Heart gene therapy data and $1.1B Alnylam deal help Tenaya fund work to 2027 - Stock Titan Wed, 11 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
93.33
-19.51%
|
115.95
-11.62%
|
131.19
+4.44%
|
125.62
|
| Research And Development |
|
68.61
-20.91%
|
86.74
-11.52%
|
98.04
+3.70%
|
94.54
|
| Selling General And Administration |
|
24.72
-15.35%
|
29.21
-11.91%
|
33.16
+6.66%
|
31.08
|
| General And Administrative Expense |
|
24.72
-15.35%
|
29.21
-11.91%
|
33.16
+6.66%
|
31.08
|
| Other Gand A |
|
24.72
-15.35%
|
29.21
-11.91%
|
33.16
+6.66%
|
31.08
|
| Total Expenses |
|
93.33
-19.51%
|
115.95
-11.62%
|
131.19
+4.44%
|
125.62
|
| Operating Income |
|
-93.33
+19.51%
|
-115.95
+11.62%
|
-131.19
-4.44%
|
-125.62
|
| Total Operating Income As Reported |
|
-93.33
+19.51%
|
-115.95
+11.62%
|
-131.19
-4.44%
|
-125.62
|
| EBITDA |
|
-84.89
+21.01%
|
-107.48
+12.27%
|
-122.51
-2.81%
|
-119.15
|
| Normalized EBITDA |
|
-84.89
+21.01%
|
-107.48
+12.27%
|
-122.51
-2.81%
|
-119.15
|
| Reconciled Depreciation |
|
8.44
-0.38%
|
8.47
-2.52%
|
8.69
+34.33%
|
6.47
|
| EBIT |
|
-93.33
+19.51%
|
-115.95
+11.62%
|
-131.19
-4.44%
|
-125.62
|
| Net Income |
|
-90.60
+18.48%
|
-111.13
+10.44%
|
-124.08
-0.34%
|
-123.67
|
| Pretax Income |
|
-90.60
+18.48%
|
-111.13
+10.44%
|
-124.08
-0.34%
|
-123.67
|
| Net Non Operating Interest Income Expense |
|
2.68
-43.38%
|
4.74
-32.87%
|
7.06
+261.11%
|
1.95
|
| Net Interest Income |
|
2.68
-43.38%
|
4.74
-32.87%
|
7.06
+261.11%
|
1.95
|
| Interest Income Non Operating |
|
2.68
-43.38%
|
4.74
-32.87%
|
7.06
+261.11%
|
1.95
|
| Interest Income |
|
2.68
-43.38%
|
4.74
-32.87%
|
7.06
+261.11%
|
1.95
|
| Other Income Expense |
|
0.05
-36.59%
|
0.08
+54.72%
|
0.05
+2550.00%
|
0.00
|
| Other Non Operating Income Expenses |
|
0.05
-36.59%
|
0.08
+54.72%
|
0.05
+2550.00%
|
0.00
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-90.60
+18.48%
|
-111.13
+10.44%
|
-124.08
-0.34%
|
-123.67
|
| Net Income From Continuing Operation Net Minority Interest |
|
-90.60
+18.48%
|
-111.13
+10.44%
|
-124.08
-0.34%
|
-123.67
|
| Net Income From Continuing And Discontinued Operation |
|
-90.60
+18.48%
|
-111.13
+10.44%
|
-124.08
-0.34%
|
-123.67
|
| Net Income Continuous Operations |
|
-90.60
+18.48%
|
-111.13
+10.44%
|
-124.08
-0.34%
|
-123.67
|
| Normalized Income |
|
-90.60
+18.48%
|
-111.13
+10.44%
|
-124.08
-0.34%
|
-123.67
|
| Net Income Common Stockholders |
|
-90.60
+18.48%
|
-111.13
+10.44%
|
-124.08
-0.34%
|
-123.67
|
| Diluted EPS |
|
—
|
-1.31
+22.02%
|
-1.68
+39.13%
|
-2.76
|
| Basic EPS |
|
—
|
-1.31
+22.02%
|
-1.68
+39.13%
|
-2.76
|
| Basic Average Shares |
|
—
|
84.82
+14.96%
|
73.79
+64.61%
|
44.82
|
| Diluted Average Shares |
|
—
|
84.82
+14.96%
|
73.79
+64.61%
|
44.82
|
| Diluted NI Availto Com Stockholders |
|
-90.60
+18.48%
|
-111.13
+10.44%
|
-124.08
-0.34%
|
-123.67
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
170.51
|
| Current Assets |
|
111.58
|
| Cash Cash Equivalents And Short Term Investments |
|
104.64
|
| Cash And Cash Equivalents |
|
45.68
|
| Other Short Term Investments |
|
58.96
|
| Receivables |
|
0.00
|
| Taxes Receivable |
|
0.00
|
| Prepaid Assets |
|
5.78
|
| Other Current Assets |
|
1.16
|
| Total Non Current Assets |
|
58.93
|
| Net PPE |
|
53.26
|
| Gross PPE |
|
77.60
|
| Accumulated Depreciation |
|
-24.34
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
20.31
|
| Construction In Progress |
|
1.73
|
| Other Properties |
|
29.95
|
| Leases |
|
25.61
|
| Investments And Advances |
|
0.00
|
| Other Non Current Assets |
|
5.68
|
| Total Liabilities Net Minority Interest |
|
31.09
|
| Current Liabilities |
|
22.73
|
| Payables And Accrued Expenses |
|
9.24
|
| Payables |
|
5.91
|
| Accounts Payable |
|
5.63
|
| Current Accrued Expenses |
|
3.33
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
8.70
|
| Total Tax Payable |
|
0.28
|
| Current Debt And Capital Lease Obligation |
|
4.32
|
| Current Capital Lease Obligation |
|
4.32
|
| Current Deferred Liabilities |
|
—
|
| Other Current Liabilities |
|
0.48
|
| Total Non Current Liabilities Net Minority Interest |
|
8.36
|
| Long Term Debt And Capital Lease Obligation |
|
8.11
|
| Long Term Capital Lease Obligation |
|
8.11
|
| Non Current Deferred Liabilities |
|
—
|
| Other Non Current Liabilities |
|
0.25
|
| Preferred Securities Outside Stock Equity |
|
—
|
| Stockholders Equity |
|
139.42
|
| Common Stock Equity |
|
139.42
|
| Capital Stock |
|
0.01
|
| Common Stock |
|
0.01
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
68.33
|
| Ordinary Shares Number |
|
68.33
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
542.80
|
| Retained Earnings |
|
-403.28
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.11
|
| Other Equity Adjustments |
|
-0.11
|
| Total Equity Gross Minority Interest |
|
139.42
|
| Total Capitalization |
|
139.42
|
| Working Capital |
|
88.85
|
| Invested Capital |
|
139.42
|
| Total Debt |
|
12.42
|
| Capital Lease Obligations |
|
12.42
|
| Net Tangible Assets |
|
139.42
|
| Tangible Book Value |
|
139.42
|
| Available For Sale Securities |
|
—
|
| Investmentin Financial Assets |
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-68.26
+24.57%
|
-90.50
+11.34%
|
-102.07
+2.25%
|
-104.42
|
| Cash Flow From Continuing Operating Activities |
|
-68.26
+24.57%
|
-90.50
+11.34%
|
-102.07
+2.25%
|
-104.42
|
| Net Income From Continuing Operations |
|
-90.60
+18.48%
|
-111.13
+10.44%
|
-124.08
-0.34%
|
-123.67
|
| Depreciation Amortization Depletion |
|
8.44
-0.38%
|
8.47
-2.52%
|
8.69
+34.33%
|
6.47
|
| Depreciation |
|
—
|
8.47
-2.52%
|
8.69
+34.33%
|
6.47
|
| Depreciation And Amortization |
|
8.44
-0.38%
|
8.47
-2.52%
|
8.69
+34.33%
|
6.47
|
| Other Non Cash Items |
|
2.90
-23.26%
|
3.77
+12.69%
|
3.35
+35.97%
|
2.46
|
| Stock Based Compensation |
|
13.05
-20.94%
|
16.50
+7.79%
|
15.31
+33.50%
|
11.47
|
| Operating Gains Losses |
|
—
|
—
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
—
|
—
|
—
|
—
|
| Change In Working Capital |
|
-2.46
+69.03%
|
-7.93
-40.42%
|
-5.65
-565.25%
|
-0.85
|
| Change In Prepaid Assets |
|
0.55
-36.17%
|
0.86
+748.51%
|
0.10
+103.44%
|
-2.93
|
| Change In Payables And Accrued Expense |
|
-0.90
+83.14%
|
-5.33
-419.10%
|
-1.03
-117.08%
|
6.01
|
| Change In Accrued Expense |
|
0.53
+111.21%
|
-4.75
-310.33%
|
2.26
-48.11%
|
4.35
|
| Change In Payable |
|
-1.43
-146.13%
|
-0.58
+82.30%
|
-3.28
-297.71%
|
1.66
|
| Change In Account Payable |
|
-1.43
-146.13%
|
-0.58
+82.30%
|
-3.28
-297.71%
|
1.66
|
| Change In Other Current Assets |
|
0.57
-12.96%
|
0.66
+209.15%
|
-0.60
+26.26%
|
-0.81
|
| Change In Other Current Liabilities |
|
-2.68
+35.02%
|
-4.12
+0.10%
|
-4.12
-32.63%
|
-3.11
|
| Investing Cash Flow |
|
56.08
+4858.71%
|
1.13
-97.68%
|
48.72
-41.76%
|
83.65
|
| Cash Flow From Continuing Investing Activities |
|
56.08
+4858.71%
|
1.13
-97.68%
|
48.72
-41.76%
|
83.65
|
| Net PPE Purchase And Sale |
|
-0.62
+39.71%
|
-1.02
+17.27%
|
-1.24
+93.99%
|
-20.63
|
| Purchase Of PPE |
|
-0.62
+39.71%
|
-1.02
+17.27%
|
-1.24
+93.99%
|
-20.63
|
| Capital Expenditure |
|
-0.62
+39.71%
|
-1.02
+17.27%
|
-1.24
+93.99%
|
-20.63
|
| Net Investment Purchase And Sale |
|
56.70
+2550.82%
|
2.14
-95.72%
|
49.98
-52.07%
|
104.27
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-87.07
-53.71%
|
-56.64
+59.68%
|
-140.48
|
| Sale Of Investment |
|
56.70
-36.44%
|
89.21
-16.33%
|
106.62
-56.44%
|
244.75
|
| Net Other Investing Changes |
|
—
|
0.02
+168.00%
|
-0.03
-412.50%
|
0.01
|
| Financing Cash Flow |
|
108.41
+127.03%
|
47.75
+1079.28%
|
4.05
-94.79%
|
77.77
|
| Cash Flow From Continuing Financing Activities |
|
108.41
+127.03%
|
47.75
+1079.28%
|
4.05
-94.79%
|
77.77
|
| Net Common Stock Issuance |
|
105.98
+126.63%
|
46.76
+1108.95%
|
3.87
-95.00%
|
77.39
|
| Common Stock Payments |
|
—
|
—
|
—
|
0.00
|
| Repurchase Of Capital Stock |
|
—
|
—
|
—
|
0.00
|
| Proceeds From Stock Option Exercised |
|
2.43
+146.00%
|
0.99
+44.72%
|
0.68
+79.47%
|
0.38
|
| Net Other Financing Charges |
|
—
|
—
|
-0.50
|
—
|
| Changes In Cash |
|
96.22
+331.19%
|
-41.62
+15.59%
|
-49.31
-186.51%
|
56.99
|
| Beginning Cash Position |
|
4.74
-89.77%
|
46.36
-51.54%
|
95.67
+147.37%
|
38.68
|
| End Cash Position |
|
100.97
+2029.19%
|
4.74
-89.77%
|
46.36
-51.54%
|
95.67
|
| Free Cash Flow |
|
-68.88
+24.74%
|
-91.53
+11.41%
|
-103.31
+17.39%
|
-125.05
|
| Amortization Of Securities |
|
0.41
+323.37%
|
-0.18
-158.41%
|
0.32
+202.61%
|
-0.31
|
| Common Stock Issuance |
|
105.98
+126.63%
|
46.76
+1108.95%
|
3.87
-95.00%
|
77.39
|
| Issuance Of Capital Stock |
|
105.98
+126.63%
|
46.76
+1108.95%
|
3.87
-95.00%
|
77.39
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-K2026-03-11 View
- 8-K2026-03-11 View
- 8-K2026-03-05 View
- 42026-02-26 View
- 42026-02-24 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-17 View
- 42026-02-12 View
- 42026-02-05 View
- 42026-02-05 View
- 42026-02-05 View
- 8-K2026-01-30 View
- 8-K2026-01-02 View
- 8-K2025-12-12 View
- 8-K2025-12-11 View
- 42025-11-17 View
- 42025-11-17 View
- 42025-11-17 View
- 10-Q2025-11-10 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|